Daniel Alcolea
Daniel Alcolea
Sant Pau Memory Unit - Hospital de la Santa Creu i Sant Pau - Barcelona (Spain)
Verified email at santpau.cat - Homepage
Cited by
Cited by
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis
WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ...
Jama 313 (19), 1924-1938, 2015
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
G Kleinberger, Y Yamanishi, M Suárez-Calvet, E Czirr, E Lohmann, ...
Science translational medicine 6 (243), 243ra86-243ra86, 2014
CSF biomarker variability in the Alzheimer's Association quality control program
N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ...
Alzheimer's & Dementia 9 (3), 251-261, 2013
sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
M Suárez‐Calvet, G Kleinberger, MÁ Araque Caballero, M Brendel, ...
EMBO molecular medicine 8 (5), 466-476, 2016
Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes
N Setó-Salvia, J Clarimón, J Pagonabarraga, B Pascual-Sedano, ...
Archives of neurology 68 (3), 359-364, 2011
Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease
P Podlesniy, J Figueiro‐Silva, A Llado, A Antonell, R Sanchez‐Valle, ...
Annals of neurology 74 (5), 655-668, 2013
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
D Alcolea, P Martínez-Lage, P Sánchez-Juan, J Olazarán, C Antúnez, ...
Neurology 85 (7), 626-633, 2015
Performance and complications of lumbar puncture in memory clinics: results of the multicenter lumbar puncture feasibility study
FH Duits, P Martinez‐Lage, C Paquet, S Engelborghs, A Lleó, L Hausner, ...
Alzheimer's & Dementia 12 (2), 154-163, 2016
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World …
P Lewczuk, P Riederer, SE O’Bryant, MM Verbeek, B Dubois, PJ Visser, ...
The world journal of biological psychiatry 19 (4), 244-328, 2018
Relationship between β-secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease
D Alcolea, M Carmona-Iragui, M Suárez-Calvet, MB Sánchez-Saudinós, ...
Journal of Alzheimer's Disease 42 (1), 157-167, 2014
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia
O Dols-Icardo, A García-Redondo, R Rojas-García, R Sánchez-Valle, ...
Human molecular genetics 23 (3), 749-754, 2014
Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer disease
J Fortea, E Vilaplana, D Alcolea, M Carmona‐Iragui, ...
Annals of neurology 76 (2), 223-230, 2014
Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer disease
M Pera, D Alcolea, R Sánchez-Valle, C Guardia-Laguarta, ...
Acta neuropathologica 125 (2), 201-213, 2013
Association of cerebral amyloid-β aggregation with cognitive functioning in persons without dementia
WJ Jansen, R Ossenkoppele, BM Tijms, AM Fagan, O Hansson, ...
JAMA psychiatry 75 (1), 84-95, 2018
Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s disease
E Rodríguez-Rodríguez, P Sánchez-Juan, JL Vázquez-Higuera, I Mateo, ...
Journal of neural transmission 120 (5), 807-812, 2013
CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration
D Alcolea, E Vilaplana, M Suárez-Calvet, I Illán-Gala, R Blesa, J Clarimón, ...
Neurology 89 (2), 178-188, 2017
Reduced slow-wave sleep is associated with high cerebrospinal fluid Aβ42 levels in cognitively normal elderly
AW Varga, ME Wohlleber, S Giménez, S Romero, JF Alonso, EL Ducca, ...
Sleep 39 (11), 2041-2048, 2016
Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
J Fortea, M Carmona-Iragui, B Benejam, S Fernández, L Videla, ...
The Lancet Neurology 17 (10), 860-869, 2018
Plasma miR-34a-5p and miR-545-3p as early biomarkers of Alzheimer’s disease: potential and limitations
M Cosín-Tomás, A Antonell, A Lladó, D Alcolea, J Fortea, M Ezquerra, ...
Molecular neurobiology 54 (7), 5550-5562, 2017
Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease
D Alcolea, E Vilaplana, J Pegueroles, V Montal, P Sánchez-Juan, ...
Neurobiology of aging 36 (6), 2018-2023, 2015
The system can't perform the operation now. Try again later.
Articles 1–20